ATNM
Price
$1.21
Change
-$0.04 (-3.20%)
Updated
Apr 17 closing price
Capitalization
37.75M
23 days until earnings call
TBPH
Price
$8.62
Change
+$0.02 (+0.23%)
Updated
Apr 17 closing price
Capitalization
431.01M
24 days until earnings call
Ad is loading...

ATNM vs TBPH

Header iconATNM vs TBPH Comparison
Open Charts ATNM vs TBPHBanner chart's image
Actinium Pharmaceuticals
Price$1.21
Change-$0.04 (-3.20%)
Volume$323.48K
Capitalization37.75M
Theravance Biopharma
Price$8.62
Change+$0.02 (+0.23%)
Volume$160.02K
Capitalization431.01M
ATNM vs TBPH Comparison Chart
Loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNM vs. TBPH commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a Hold and TBPH is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (ATNM: $1.21 vs. TBPH: $8.62)
Brand notoriety: ATNM and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 44% vs. TBPH: 64%
Market capitalization -- ATNM: $37.75M vs. TBPH: $431.01M
ATNM [@Biotechnology] is valued at $37.75M. TBPH’s [@Biotechnology] market capitalization is $431.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileTBPH’s FA Score has 0 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • TBPH’s FA Score: 0 green, 5 red.
According to our system of comparison, TBPH is a better buy in the long-term than ATNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 3 TA indicator(s) are bullish while TBPH’s TA Score has 4 bullish TA indicator(s).

  • ATNM’s TA Score: 3 bullish, 7 bearish.
  • TBPH’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, TBPH is a better buy in the short-term than ATNM.

Price Growth

ATNM (@Biotechnology) experienced а +5.22% price change this week, while TBPH (@Biotechnology) price change was +2.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

ATNM is expected to report earnings on Jul 28, 2025.

TBPH is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TBPH($431M) has a higher market cap than ATNM($37.7M). ATNM YTD gains are higher at: -3.968 vs. TBPH (-8.395). TBPH has higher annual earnings (EBITDA): -38.45M vs. ATNM (-44.15M). TBPH has more cash in the bank: 88.4M vs. ATNM (78.7M). ATNM has less debt than TBPH: ATNM (1.71M) vs TBPH (49.8M). TBPH has higher revenues than ATNM: TBPH (64.4M) vs ATNM (81K).
ATNMTBPHATNM / TBPH
Capitalization37.7M431M9%
EBITDA-44.15M-38.45M115%
Gain YTD-3.968-8.39547%
P/E RatioN/AN/A-
Revenue81K64.4M0%
Total Cash78.7M88.4M89%
Total Debt1.71M49.8M3%
FUNDAMENTALS RATINGS
ATNM vs TBPH: Fundamental Ratings
ATNM
TBPH
OUTLOOK RATING
1..100
8958
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
41
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
6357
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TBPH's Valuation (41) in the Pharmaceuticals Other industry is somewhat better than the same rating for ATNM (75) in the Biotechnology industry. This means that TBPH’s stock grew somewhat faster than ATNM’s over the last 12 months.

TBPH's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ATNM (100) in the Biotechnology industry. This means that TBPH’s stock grew similarly to ATNM’s over the last 12 months.

TBPH's SMR Rating (96) in the Pharmaceuticals Other industry is in the same range as ATNM (98) in the Biotechnology industry. This means that TBPH’s stock grew similarly to ATNM’s over the last 12 months.

TBPH's Price Growth Rating (57) in the Pharmaceuticals Other industry is in the same range as ATNM (63) in the Biotechnology industry. This means that TBPH’s stock grew similarly to ATNM’s over the last 12 months.

TBPH's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as ATNM (100) in the Biotechnology industry. This means that TBPH’s stock grew similarly to ATNM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATNMTBPH
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
72%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
72%
Advances
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 5 days ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
75%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
74%
View a ticker or compare two or three
Ad is loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X84895.750000861.882800
+1.03%
Bitcoin cryptocurrency
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with GBIO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
-3.20%
GBIO - ATNM
47%
Loosely correlated
+13.03%
ABOS - ATNM
35%
Loosely correlated
-8.08%
IMNM - ATNM
35%
Loosely correlated
+10.32%
ABCL - ATNM
34%
Loosely correlated
+1.26%
PRLD - ATNM
34%
Loosely correlated
+5.19%
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with ELEV. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then ELEV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
+0.29%
ELEV - TBPH
42%
Loosely correlated
+16.72%
KOD - TBPH
31%
Poorly correlated
+20.34%
CYTK - TBPH
28%
Poorly correlated
+0.84%
ATNM - TBPH
28%
Poorly correlated
-3.20%
AUTL - TBPH
28%
Poorly correlated
+5.93%
More